1st ANNUAL TEXAS HOLD'EM POKER TOURNAMENT

TO BENEFIT PROSTATE CANCER RESEARCH IN COLORADO

-Aurora, Colorado

Spencer Green, Clinical Director of Research for the University of Colorado Health Sciences Center's leading group of Colorado Prostate Cancer specialists, has announced the 1 st Annual Texas Hold'Em Benefit Poker Tournament will be held on Saturday, March 24, 2007 beginning at 1:00 PM at Table Steaks East, 3523 S. Parker Road in Aurora, Colorado.

"The fact is nearly a quarter of a million American men will be diagnosed with prostate cancer this year which translates to one in six men. However, if there is a history of this illness in the family or the man is African American, the likelihood increases to one in three men", says Green, adding, "Colorado simply does not get the funding it needs, either from the federal government or the national prostate foundation, to support necessary research, pay for community education or provide affordable access to medical treatment and screenings that are critically needed for Coloradans today."

World recognized prostate cancer physicians, Dr. L. Michael Glode, Dr. E. David Crawford and Dr. M Scott Lucia with the University of Colorado Health Sciences Center are the Progress for Prostate Foundation's scientific medical advisors who are seeking to advance A Colorado Solution™ by holding community-shared benefit events throughout the year where every dollar raised goes towards supporting Prostate Research at the University of Colorado.

Participation in the Texas Hold'Em Poker Tournament is open to the general public (must be 21 and over to play) by advance reservation as space allows and requires a minimum $100 (tax deductible) donation to the Progress for Prostate Foundation™. Players will also receive free food, beverages, and several chances to win door prizes such as a flat screen television, autographed pro sports memorabilia and gift certificates to local restaurants. Corporate table sponsorships range from $150 to $2,000 offering various levels of event sponsor visibility. No poker experience is necessary as professional dealers will help explain the rules and conduct the games.

"We also have NFL sports celebrities and others who are planning on joining us in this very fun day where every donation will help make significant progress in advancing treatment for an illness that happens to have a highly survivable and curable outcome if caught early," says Green.

Online registration is available at www.progress4prostate.org or by calling 303-798-1338 for more information. A minimum donation of $100 ensures a place at a table or a ticket to observe.

Media interviews are available by appointment. Contact Spencer Green, 303-798-1338. Following are abbreviated bios for the above named physicians.

Dr. E. David Crawford

Dr. Crawford is a world recognized expert in prostate cancer here in Colorado. He has conducted research in the treatment of pre and post-metastic adeno-carcinoma of the prostate, hormone-refractory prostate cancer, bladder cancer, and other areas of urological infections and malignancies.

He has authored or coauthored over 400 articles, which have been published in such journals as Urology, The New England Journal of Medicine, and the Journal of the National Cancer Institute. He is also an editorial reviewer or consultant for a large number of publications, including Urology, Journal of Urology, The New England Journal of Medicine, Cancer, and the Journal of Clinical Oncology. He is one of the co-founders of Prostate Cancer Awareness Week (PCAW), which provides free or low cost prostate cancer screenings for men across the US every September.

Dr. M. Scott Lucia

Dr. Lucia is Associate Professor and Chief of Genitourinary and Renal Pathology at the University of Colorado Denver and Health Sciences Center where he also serves as the Director of the Prostate Diagnostic Laboratory and Co-Director of the Prostate Cancer Research Laboratories. Dr. Lucia received his M.D. from the University of Colorado School of Medicine in 1988. He completed his internship and residency in pathology at the University of Colorado in 1993. He was a research fellow in the Laboratory of Chemoprevention at the National Institutes of Health from 1993-1995 before returning to Colorado in 1995.

Dr. Lucia served as the primary pathologist for the Prostate Cancer Prevention Trial (PCPT) and the Medical Therapy of Prostate Symptoms (MTOPS) trial. He currently is the primary pathologist for the Vitamin E and Selenium Chemoprevention Trial (SELECT). Dr. Lucia directs the operation of several tissue and serum biorepositories for prostate and prostatic diseases accounting for one of the largest collections of prostate research samples in the world. He has authored over 50 peer-reviewed articles and book chapters. His research is focused on pathology of prostate cancer and hyperplasia, early detection and prevention of prostate cancer, and mechanisms of carcinogenesis.

Dr. L. Michael Glode

Dr. Glode is Chief Medical Oncologist for University of Colorado Cancer Center's Urologic Oncology Division. He has a long standing interest in GU oncology, specialized in Prostate Cancer. He was Principal Investigator (PI) on the study leading to approval of leuprolide, which is the top hormone therapy used to fight prostate cancer. He is currently PI on the only national NCI sponsored adjuvant treatment protocol for high risk prostate cancer patients following surgery. His laboratory examinations include studies for development of new prostate and bladder cancer fighting agents.